31 – 40 of 134
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Why Is Amyloid-β PET Requested After Performing CSF Biomarkers?
- Contribution to journal › Article
-
Mark
Trapped fourth ventricle : a rare complication in children after supratentorial CSF shunting
- Contribution to journal › Article
-
Mark
Relevance of biomarkers across different neurodegenerative
- Contribution to journal › Scientific review
-
Mark
Biomarker profiling beyond amyloid and tau : cerebrospinal fluid markers, hippocampal atrophy, and memory change in cognitively unimpaired older adults
- Contribution to journal › Article
-
Mark
Propagation of Tau Pathology : Integrating Insights From Postmortem and In Vivo Studies
- Contribution to journal › Scientific review
-
Mark
Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders
- Contribution to journal › Article
- 2019
-
Mark
PDGF-B Is Required for Development of the Glymphatic System
- Contribution to journal › Article
-
Mark
Novel tau fragments in cerebrospinal fluid : relation to tangle pathology and cognitive decline in Alzheimer’s disease
- Contribution to journal › Article
-
Mark
Cisterna Magna Injection in Rats to Study Glymphatic Function
- Contribution to journal › Article
-
Mark
Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease : Cross-validation study of practical algorithms
- Contribution to journal › Article
